Federal Trade Commission accuses three drug middlemen of inflating insulin prices
In a lawsuit, the FTC accused Optum Rx, Caremark and Express Scripts of creating "a broken rebate system that inflated insulin drug prices, boosting PBM (prescription drug benefit managers) profits at the expense of vulnerable patients.
At the Federal Trade Commission, Chair Lina Khan's mission is breaking illegal monopolies, blocking mergers that stifle competition, and protecting consumers.
The Federal Trade Commission (FTC) filed a lawsuit Friday against three major prescription drug benefit managers (PBMs) and ...
It’s been almost a month since the new FTC rule was officially approved, but if you still can’t smell what The Rock-a-Khan is ...
Federal Trade Commission Chair Lina Khan has gone after some of the biggest companies in the U.S. Under President Biden, the FTC has cracked down on big companies they say are hurting consumers.
A Federal Trade Commission (FTC) report found that social and video streaming services pose serious privacy risks, especially ...
The federal government is suing some big pharmacy benefit managers over a system of drug rebates that regulators say has made ...
In an interview with 60 Minutes, the Federal Trade Commission head said the agency believes it has the authority to ban ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback